Nebivolol in the management of essential hypertension: a review.
about
Nebivolol: a novel beta-blocker with nitric oxide-induced vasodilatationNebivolol: third-generation beta-blockadeRationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.Beneficial effects of nebivolol in comparison with atenolol on safety and tolerability in essential hypertension.A comparative study of nebivolol and (S) atenolol on blood pressure and heart rate on essential hypertensive patients.Predictors of switching from beta-blockers to other anti-hypertensive drugs: a review of records of 19,177 Chinese patients seen in public primary care clinics in the New Territory East, Hong Kong.Chronic Nebivolol Treatment Suppresses Endothelin-1-Mediated Vasoconstrictor Tone in Adults With Elevated Blood Pressure.Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker.Nebivolol (bystolic), a novel Beta blocker for hypertensionPulmonary effects of nebivolol.Protective effects of nebivolol from oxidative stress to prevent hypertension-related target organ damage.Allergic contact dermatitis to nebivolol.Effect of nebivolol on left ventricular function in patients with chronic heart failure: a pilot study.The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.Adding nebivolol to ongoing antihypertensive therapy improves blood pressure and response rates in patients with uncontrolled stage I-II hypertension.Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?Nebivolol induces a hyperpolarizing effect on smooth muscle cells in the mouse renal artery by activation of beta-2-adrenoceptors.Both carvedilol and nebivolol may improve platelet function and prothrombotic state in patients with nonischemic heart failure.
P2860
Q24681317-F5067C18-CB77-4CD8-8A2D-595A155CDD4BQ28238369-E5F69547-3BC0-4204-A25E-9975BB2ACAEFQ30491698-084CFFB4-F0B2-4CDD-976F-17120EAD8FD3Q34030454-442CCDBC-B1DF-4BFA-94AA-78E3CDD7A847Q34349839-85940E5A-68F4-49D1-821C-9167E15D382CQ35181686-D49F02ED-49D8-4366-8B5C-687D01CCFE5CQ36912685-C7BF8ED6-AEA4-4AF7-BD1A-24AC03F3732EQ37033656-8D37A2D2-AE3D-4AB6-9A95-C3428FB7AF41Q37229207-1F3256C5-6FA7-4C4C-8A11-F9A25D4309FCQ37564736-9154EEC4-CD2E-47D7-9FDA-98D01A0E1CA3Q39157832-922FF608-159A-46CB-96E2-12A9C8DBA8E4Q44095513-74EF24DF-BB48-4D9D-8EB6-EBC63E3A3234Q44230616-53772092-44F0-4772-AD91-58C190A57256Q44479268-3A1875F9-613D-4916-BF81-738157BFAC6AQ46031238-F2883440-A326-4DD6-AA6D-0059B2172A8FQ46816143-3A248B23-56A8-4185-B694-E1B078D64578Q46938751-070CEC1C-B85B-4AD3-9107-BF93C592F37EQ50996233-226EFE68-B47E-45BB-BCF5-3F6AF6E9B942
P2860
Nebivolol in the management of essential hypertension: a review.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Nebivolol in the management of essential hypertension: a review.
@ast
Nebivolol in the management of essential hypertension: a review.
@en
type
label
Nebivolol in the management of essential hypertension: a review.
@ast
Nebivolol in the management of essential hypertension: a review.
@en
prefLabel
Nebivolol in the management of essential hypertension: a review.
@ast
Nebivolol in the management of essential hypertension: a review.
@en
P1433
P1476
Nebivolol in the management of essential hypertension: a review.
@en
P2093
P304
P356
10.2165/00003495-199957040-00011
P577
1999-04-01T00:00:00Z
P6179
1017021637